Document is current

Any future updates will be listed below

Clinical and biomarker analyses of SHR-1701 combined with famitinib in patients with previously treated advanced biliary tract cancer or pancreatic ductal adenocarcinoma: a phase II trial

Crossref DOI link: https://doi.org/10.1038/s41392-024-02052-3

Published Online: 2024-12-13

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark